Navigation Links
Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Date:9/16/2010

EMERYVILLE, Calif., Sept. 16 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the UBS Global Life Sciences Conference on Wednesday, September 22, 2010 at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time).

Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through October 6, 2010.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a selective proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, an alpha-folate receptor targeted inhibitor of thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-phar
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
(Date:5/27/2015)... 27, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... pharmaceutical company, today updated its full year 2015 financial ... Full Year 2015 Updated Financial Guidance , ... 2015 are still expected to be between $7.0 and ... in total revenue for the remainder of the year, ...
(Date:5/27/2015)... May 27, 2015 Encision Inc. (OTCQB:ECIA), a ... dangerous stray electrosurgical burns in minimally invasive surgery, today ... and fiscal year ended March 31, 2015. ... for a quarterly net loss of $349 thousand, or ... of $2.504 million for a net loss of $1.453 ...
Breaking Medicine Technology:China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2IGI Laboratories Updates Business Outlook 2IGI Laboratories Updates Business Outlook 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... May 27, 2015 With InnerVoice Communication ... environment where the message is not only heard but seen ... or virtually any motivating image. This award-winning and affordable app ... , Now, using InnerVoice Sender app in ... sent to a learner remotely for no additional cost. , ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 For a limited ... Ghasri, is now offering discounts on facial fillers. Skin loses ... the age of 18. This lost collagen can lead to ... wrinkles and expression lines. Facial fillers are an excellent way ... turn to facial fillers to create a softer and more ...
(Date:5/27/2015)... May 27, 2015 Decorview , ... America, is offering free design advice to homeowners looking ... , “Light pollution caused by streetlights, outdoor signs, ... restless night’s sleep, said Kim Rush, VP of sales ... cities across North America with recently installed LED streetlights– ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
Breaking Medicine News(10 mins):Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:CRN International Names New Chief Financial Officer 2
... for years may be embarrassed to let a spouse or partner ... shyness can hamper a couple,s willingness to do total body skin ... melanoma. Melanoma, the most deadly form of skin cancer, can appear ... "I had a woman tell me, ,I don,t want my husband ...
... DE May 20, 2008 A new ... therapy and fluticasone/salmeterol combination therapy, as measured by ... in the study were ages 18 years and ... been previously treated with inhaled corticosteroids.1 Results were ...
... It is not uncommon to find tissue that normally lines ... "heterotopic" gastric tissue has been identified in such diverse locations ... , This case, reported by a team led by Dr. ... edition of the World Journal of Gastroenterology. , Typically, when ...
... than a dose-response effect on mortality from alcohol-related liver ... beverage, was more significant to liver injury. , This ... You-Ming Li from Zhejiang University, is described in a ... in the World Journal of Gastroenterology. , The study ...
... with cirrhosis of the liver develop abnormally dilated blood ... vomiting may occur from the rupture of these varices, ... eradicate these varices. To achieve this, an elastic band ... allows the consecutive application of up to six rubber ...
... and calm, according to a new study from the Population ... at about age 60, participants reported more feelings of ease ... John Mirowsky, professors of sociology, have published the findings in ... issue of Social Science and Medicine. The research was funded ...
Cached Medicine News:Health News:A loving partner can save your skin 2Health News:A loving partner can save your skin 3Health News:Heterotopic gastric tissue simulating acute appendicitis 2Health News:How to save cost for esophageal varices? 2Health News:With age comes a sense of peace and calm 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: